| Literature DB >> 27929076 |
N De Zutter1,2, K Audenaert2, N Arroyo-Manzanares3, M De Boevre3, C Van Poucke3, S De Saeger3, G Haesaert2, G Smagghe1.
Abstract
Biotransformation of mycotoxins in animals comprises phase I and phase II metabolisation reactions. For the trichothecene deoxynivalenol (DON), several phase II biotransformation reactions have been described resulting in DON-glutathiones, DON-glucuronides and DON-sulfates made by glutathione-S-transferases, uridine-diphosphoglucuronyl transferases and sulfotransferases, respectively. These metabolites can be easily excreted and are less toxic than their free compounds. Here, we demonstrate for the first time in the animal kingdom the conversion of DON to DON-3-glucoside (DON-3G) via a model system with plant pathogenic aphids. This phase II biotransformation mechanism has only been reported in plants. As the DON-3G metabolite was less toxic for aphids than DON, this conversion is considered a detoxification reaction. Remarkably, English grain aphids (Sitobion avenae) which co-occur with the DON producer Fusarium graminearum on wheat during the development of fusarium symptoms, tolerate DON much better and convert DON to DON-3G more efficiently than pea aphids (Acyrthosiphon pisum), the latter being known to feed on legumes which are no host for F. graminearum. Using a non-targeted high resolution mass spectrometric approach, we detected DON-diglucosides in aphids probably as a result of sequential glucosylation reactions. Data are discussed in the light of an eventual co-evolutionary adaptation of S. avenae to DON.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27929076 PMCID: PMC5144147 DOI: 10.1038/srep38640
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Chemical structure of the mycotoxin deoxynivalenol (DON).
Percentage survival ± S.E. of S. avenae aphids and A. pisum aphids feeding from diet containing different concentrations of deoxynivalenol.
| Concentration | |||
|---|---|---|---|
| Control | 97 ± 3a | 100 ± 0a | |
| DON | 0.5 mg l−1 | 93 ± 3a (p = 1.000) | 62 ± 6bc (p = 0.024) |
| 1 mg l−1 | 93 ± 2a (p = 1.000) | 48 ± 9c (p = 0.006) | |
| 3 mg l−1 | 93 ± 4a (p = 1.000) | 50 ± 11c (p = 0.012) | |
| DON-3G | 0.5 mg l−1 | 88 ± 6a (p = 1.000) | 88 ± 5ab (p = 1.000) |
| 1 mg l−1 | 89 ± 5a (p = 1.000) | 96 ± 2ab (p = 1.000) | |
| 3 mg l−1 | 81 ± 7a (p = 0.160) | 88 ± 6ab (p = 1.000) |
Each treatment consisted of 3 feeding apparatuses each containing 10 nymphs per species. Different letters indicate significant differences (P < 0.05) between treatments using a two-sided non-parametric Kruskall-Wallis test followed by a Dunn’s test for pairwise comparisons. The statistical significances in pairwise comparisons with the control treatments are depicted as a p-value between brackets (this p-value was corrected for multiple pairwise comparisons).
Figure 2Long-term survival of S. avenae aphids (A) and A. pisum aphids (B) (means ± SE) feeding on diet with increasing concentrations of deoxynivalenol (DON) (0 → 5 mg l−1). The purple line indicates the mortality of the aphids relative to the surviving fraction at each time point. *Indicates significant differences (p < 0.05) between treatment and control using one-sided t-tests.
Figure 3Relative concentrations (%) of deoxynivalenol (DON), deoxynivalenol-3-glucoside (DON-3G) compared to the total DON titer in S. avenae and A. pisum aphids after two days of feeding on artificial diet amended with 100 mg l−1 DON.
Different letters indicate significant differences (p < 0.05) between treatments using a one-way ANOVA with a post-hoc Tukey test.
Figure 4Proposed chemical structure of deoxynivalenol-diglucoside.